Literature DB >> 12626143

Chromosomal abnormalities in a series of 6,733 human oocytes in preimplantation diagnosis for age-related aneuploidies.

Anver Kuliev1, Jeanine Cieslak, Yury Ilkevitch, Yury Verlinsky.   

Abstract

Most chromosomal abnormalities originate from female meiosis and contribute significantly to pregnancy failures, particularly in women of advanced maternal age. A total of 8,382 oocytes were obtained in 1,297 IVF cycles from patients of advanced maternal age (mean 38.5 years). Following a standard IVF protocol, oocytes were tested following removal and fluorescence in-situ hybridization (FISH) analysis of the first (PB1) and second polar bodies (PB2), using probes specific for chromosomes 13, 16, 18, 21 and 22 (Vysis). FISH results were available in 67,33 (80.3%) oocytes tested, 3,509 (52.1%) of which were aneuploid, with the remaining 3,224 (47.9%) normal oocytes available for transfer. In all, 41.7% of oocytes had meiosis I errors, compared to 35.1% with meiosis II errors. Abnormalities in meiosis I were represented by extra chromatids in 15.4%, missing chromatids in 48.1%, missing chromosomes in 5.9%, extra chromosomes in 0.5%, and complex abnormalities in 30.1%. The proportions of abnormal oocytes with missing or extra chromatids in meiosis II were 36.6 and 41.2% respectively, with the remaining oocytes having complex abnormalities, involving missing or extra chromatids of different chromosomes (22.1%) following meiosis II. Overall, 41.8% oocytes had meiosis I, 30.7% meiosis II, and 27.6% both meiotic division errors. A total of 45.1% of the abnormal oocytes had complex errors, involving the same chromosome in both meiotic divisions (21.5%), or different chromosomes (78.5%), of which 74.8% were with abnormalities of two, and 25.2% with abnormalities of three chromosomes studied. Of 3,224 detected aneuploidy-free zygotes, 2,587 were transferred in 1,100 treatment cycles (2.35 embryos per transfer), resulting in 241 (21.9%) clinical pregnancies and 176 healthy children born, suggesting a positive clinical outcome following aneuploidy testing of oocytes in a group of IVF patients of average age 38.5 years.

Entities:  

Mesh:

Year:  2003        PMID: 12626143     DOI: 10.1016/s1472-6483(10)62055-x

Source DB:  PubMed          Journal:  Reprod Biomed Online        ISSN: 1472-6483            Impact factor:   3.828


  31 in total

1.  Preimplantation genetic diagnosis for Down syndrome pregnancy.

Authors:  Yu Zhang; Chen-ming Xu; Yi-min Zhu; Min-yue Dong; Yu-li Qian; Fan Jin; He-feng Huang
Journal:  J Zhejiang Univ Sci B       Date:  2007-07       Impact factor: 3.066

Review 2.  Parthenotes as a source of embryonic stem cells.

Authors:  T A L Brevini; F Gandolfi
Journal:  Cell Prolif       Date:  2008-02       Impact factor: 6.831

3.  Polar body diagnosis - a step in the right direction?

Authors:  Katrin van der Ven; Markus Montag; Hans van der Ven
Journal:  Dtsch Arztebl Int       Date:  2008-03-14       Impact factor: 5.594

4.  The origin and impact of embryonic aneuploidy.

Authors:  Elpida Fragouli; Samer Alfarawati; Katharina Spath; Souraya Jaroudi; Jonas Sarasa; Maria Enciso; Dagan Wells
Journal:  Hum Genet       Date:  2013-04-26       Impact factor: 4.132

Review 5.  Chromosomal disorders and male infertility.

Authors:  Gary L Harton; Helen G Tempest
Journal:  Asian J Androl       Date:  2011-11-28       Impact factor: 3.285

6.  Follicular fluid protein content (FSH, LH, PG4, E2 and AMH) and polar body aneuploidy.

Authors:  I Hammoud; F Vialard; M Bergere; M Albert; D Molina Gomes; M Adler; L Malagrida; M Bailly; R Wainer; J Selva
Journal:  J Assist Reprod Genet       Date:  2012-08-14       Impact factor: 3.412

7.  Predicting aneuploidy in human oocytes: key factors which affect the meiotic process.

Authors:  L Gianaroli; M C Magli; G Cavallini; A Crippa; A Capoti; S Resta; F Robles; A P Ferraretti
Journal:  Hum Reprod       Date:  2010-07-08       Impact factor: 6.918

8.  Prediction of pregnancy in IVF cycles on the fourth day of ovarian stimulation.

Authors:  J Carrera-Rotllan; L Estrada-García; J Sarquella-Ventura
Journal:  J Assist Reprod Genet       Date:  2007-06-28       Impact factor: 3.412

Review 9.  Parthenogenesis as an approach to pluripotency: advantages and limitations involved.

Authors:  Tiziana A L Brevini; Georgia Pennarossa; Stefania Antonini; Fulvio Gandolfi
Journal:  Stem Cell Rev       Date:  2008-06-12       Impact factor: 5.739

10.  Preclinical validation of a microarray method for full molecular karyotyping of blastomeres in a 24-h protocol.

Authors:  D S Johnson; G Gemelos; J Baner; A Ryan; C Cinnioglu; M Banjevic; R Ross; M Alper; B Barrett; J Frederick; D Potter; B Behr; M Rabinowitz
Journal:  Hum Reprod       Date:  2010-01-24       Impact factor: 6.918

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.